First Manhattan’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-215,722
| Closed | -$21.4M | – | 1433 |
|
|
2019
Q3 | $21.4M | Sell |
215,722
-75
| -0% | -$7.13K | 0.12% | 107 |
|
|
2019
Q2 | $19.9M | Sell |
215,797
-60
| -0% | -$5.7K | 0.11% | 111 |
|
|
2019
Q1 | $20.4M | Buy |
215,857
+127,555
| +144% | +$11.2M | 0.12% | 107 |
|
|
2018
Q4 | $5.66M | Sell |
88,302
-32,030
| -27% | -$2.36M | 0.04% | 223 |
|
|
2018
Q3 | $10.8M | Sell |
120,332
-2,943
| -2% | -$260K | 0.06% | 176 |
|
|
2018
Q2 | $9.79M | Sell |
123,275
-54,659
| -31% | -$4.54M | 0.06% | 184 |
|
|
2018
Q1 | $15.9M | Sell |
177,934
-57,905
| -25% | -$5.56M | 0.09% | 140 |
|
|
2017
Q4 | $24.6M | Buy |
235,839
+54,275
| +30% | +$6.12M | 0.13% | 114 |
|
|
2017
Q3 | $26.5M | Sell |
181,564
-1,115
| -0.6% | -$152K | 0.15% | 113 |
|
|
2017
Q2 | $23.7M | Sell |
182,679
-4,556
| -2% | -$558K | 0.14% | 120 |
|
|
2017
Q1 | $23.3M | Buy |
187,235
+46,940
| +33% | +$5.62M | 0.14% | 113 |
|
|
2016
Q4 | $16.2M | Sell |
140,295
-3,853
| -3% | -$429K | 0.1% | 134 |
|
|
2016
Q3 | $15.1M | Sell |
144,148
-3,682
| -2% | -$398K | 0.09% | 145 |
|
|
2016
Q2 | $14.6M | Buy |
147,830
+2,095
| +1% | +$217K | 0.09% | 150 |
|
|
2016
Q1 | $14.6M | Buy |
145,735
+1,137
| +0.8% | +$117K | 0.09% | 143 |
|
|
2015
Q4 | $17.3M | Sell |
144,598
-3,057
| -2% | -$354K | 0.11% | 127 |
|
|
2015
Q3 | $16M | Buy |
147,655
+225
| +0.2% | +$27.9K | 0.1% | 129 |
|
|
2015
Q2 | $17.1M | Sell |
147,430
-370
| -0.3% | -$42.3K | 0.1% | 128 |
|
|
2015
Q1 | $17M | Sell |
147,800
-673
| -0.5% | -$80.4K | 0.1% | 135 |
|
|
2014
Q4 | $16.6M | Sell |
148,473
-1,777
| -1% | -$187K | 0.09% | 139 |
|
|
2014
Q3 | $14.2M | Sell |
150,250
-400
| -0.3% | -$36.1K | 0.08% | 150 |
|
|
2014
Q2 | $12.9M | Sell |
150,650
-204
| -0.1% | -$15.5K | 0.08% | 155 |
|
|
2014
Q1 | $10.5M | Sell |
150,854
-3,500
| -2% | -$277K | 0.07% | 164 |
|
|
2013
Q4 | $13M | Sell |
154,354
-8,220
| -5% | -$650K | 0.09% | 150 |
|
|
2013
Q3 | $12.5M | Sell |
162,574
-2,340
| -1% | -$164K | 0.09% | 148 |
|
|
2013
Q2 | $11.8M | Buy |
+164,914
| New | +$9.92M | 0.08% | 151 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
First Manhattan's CELG Position: Q4 2019 in Review
First Manhattan sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 215,722 shares — an estimated $21.4M sold.
First Manhattan first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $26.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- First Manhattan reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- First Manhattan sold 215,722 Celgene Corp shares in Q4 2019, an estimated $21.4M.
- First Manhattan first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- First Manhattan's Celgene Corp position peaked at $26.5M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on First Manhattan's 13F filing for Q4 2019, filed 13 Feb 2020.